To evaluate further the feasibility of HLA typing for prenatal diagnosis, we tested human amniotic fluid cells (AFC), known to express HLA‐A, ‐B, and ‐C antigens, for the presence of HLA‐DR antigens using type‐specific antisera in the microcytotoxicity assay and a monoclonal antibody directed against the common HLA‐DR structure (cDR) in indirect immunofluorescence. Prenatal typing of HLA‐DR on AFC in the microcytotoxicity test was possible in only one out of eight families studied. The detected DR2 antigen was confirmed by postnatal typings of cord blood lymphocytes. Thereafter, 23 different AFC cultures were tested with monoclonal antibodies in indirect immunofluorescence. Only six cultures were partially positive (23–35% fluorescent cells) with the monoclonal cDR antibody while all AFC cultures demonstrated strong positive fluorescence (68–100%) with a monoclonal antibody against the common HLA‐A, ‐B, and ‐C structure (cHLA). These data suggest that only a small subpopulation of AFC expresses class II (HLA‐DR) antigens in contrast to the nearly ubiquitous expression of class I (HLA‐A, ‐B, and ‐C) antigens. Furthermore, the heterogeneous expression of cell surface antigens within the various AFC cultures was substantiated with monoclonal antibodies directed towards cell surface antigens of the OKT, OKM, and Lyt series that have been found to be characteristic for subpopulations of lymphoid and hemapoetic cells. Thus, at present, HLA‐DR typing is no